Literature DB >> 15019983

Another face of the Treacher Collins syndrome (TCOF1) gene: identification of additional exons.

Rolando B So1, Bianca Gonzales, Dale Henning, Jill Dixon, Michael J Dixon, Benigno C Valdez.   

Abstract

Treacher Collins syndrome (TCS) is characterized by an abnormality in craniofacial development during early embryogenesis. TCS is caused by mutations in the gene TCOF1, which encodes the nucleolar phosphoprotein treacle. Genetic and proteomic characterizations of TCS/treacle are based on the previously reported 26 exons of TCOF1. Here, we report the identification of 231-nucleotide (nt) exon 6A (between exons 6 and 7) and 108-nt exon 16A (between exons 16 and 17). Isoforms with exon 6A are up to 3.7-fold more abundant than alternatively spliced variants without exon 6A, but only minor isoforms contain exon 16A. Exon 6A encodes a peptide sequence containing basic and acidic domains similar to 10 other exons of TCOF1. Unlike the other exons, exon 6A encodes a nuclear localization signal (NLS) which does not, however, alter the nucleolar localization of full-length treacle. The discovery of exons 6A and 16A is relevant to mutational analysis of the TCOF1 gene in TCS patients, and to functional analysis of its gene product.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019983     DOI: 10.1016/j.gene.2003.11.027

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  17 in total

1.  Gross deletions in TCOF1 are a cause of Treacher-Collins-Franceschetti syndrome.

Authors:  Michael Bowman; Michael Oldridge; Caroline Archer; Anthony O'Rourke; Joanna McParland; Roel Brekelmans; Anneke Seller; Tracy Lester
Journal:  Eur J Hum Genet       Date:  2012-02-08       Impact factor: 4.246

Review 2.  Diamond-Blackfan anemia: diagnosis, treatment, and molecular pathogenesis.

Authors:  Jeffrey M Lipton; Steven R Ellis
Journal:  Hematol Oncol Clin North Am       Date:  2009-04       Impact factor: 3.722

Review 3.  Rare syndromes of the head and face: mandibulofacial and acrofacial dysostoses.

Authors:  Karla Terrazas; Jill Dixon; Paul A Trainor; Michael J Dixon
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2017-02-10       Impact factor: 5.814

4.  First Report of a Single Exon Deletion in TCOF1 Causing Treacher Collins Syndrome.

Authors:  J Beygo; K Buiting; S Seland; H-J Lüdecke; U Hehr; C Lich; B Prager; D R Lohmann; D Wieczorek
Journal:  Mol Syndromol       Date:  2012-01-26

5.  The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor.

Authors:  Benigno C Valdez; Dale Henning; Rolando B So; Jill Dixon; Michael J Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

6.  Reduced TCOF1 mRNA level in a rhesus macaque with Treacher Collins-like syndrome: further evidence for haploinsufficiency of treacle as the cause of disease.

Authors:  Kathryn H Shows; Christy Ward; Laura Summers; Lin Li; Gregory R Ziegler; Andrew G Hendrickx; Rita Shiang
Journal:  Mamm Genome       Date:  2006-02-07       Impact factor: 2.957

7.  Regulation of the mouse Treacher Collins syndrome homolog (Tcof1) promoter through differential repression of constitutive expression.

Authors:  Kathryn H Shows; Rita Shiang
Journal:  DNA Cell Biol       Date:  2008-11       Impact factor: 3.311

8.  Identification of a novel TCOF1 mutation in a Chinese family with Treacher Collins syndrome.

Authors:  Zhiqiang Yan; Yu Lu; Yanfei Wang; Xiuju Zhang; Hong Duan; Jing Cheng; Huijun Yuan; Dongyi Han
Journal:  Exp Ther Med       Date:  2018-07-16       Impact factor: 2.447

9.  Novel insertion in exon 5 of the TCOF1 gene in twin sisters with Treacher Collins syndrome.

Authors:  Bożena Anna Marszałek-Kruk; Piotr Wójcicki; Robert Smigiel; Wiesław H Trzeciak
Journal:  J Appl Genet       Date:  2012-03-14       Impact factor: 3.240

10.  Novel mutations of TCOF1 gene in European patients with Treacher Collins syndrome.

Authors:  Chiara Conte; Maria Rosaria D'Apice; Fabrizio Rinaldi; Stefano Gambardella; Federica Sangiuolo; Giuseppe Novelli
Journal:  BMC Med Genet       Date:  2011-09-27       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.